Search

Tata 1mg FY22 revenue up 66% to Rs 222 cr; net loss narrows to Rs

$ 15.00 · 4.6 (330) · In stock

Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler.
Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler.

Tata 1mg - Company Report - 2023 - Tracxn

Tata 1mg Achieves Remarkable Growth: FY23 Revenue Soars 2.5X To Impressive Rs 1,627 Crores - Inventiva

Govt May Soon Ban Pharmacy Apps Like Tata 1mg, NetMeds,, 47% OFF

Tata 1mg - Raised $231M Funding from 39 investors - Tracxn

We are set to conduct the biggest fashion festive sale: Myntra CEO

Tata 1MG FY22 Loss Widens To INR 526 Cr Despite Over 2X Jump In Operating Revenue

1mg: Latest News Headlines, Videos and Photo Galleries on 1mg

Tata 1mg's Net Loss Soars 2.3X To INR 1,259 Cr In FY23

1mg, Latest & Breaking News on 1mg

Tata 1MG's growth prescription

Indian Startup FY23 Financials Tracker: Revenue, Expense, Loss & More

Tata 1MG's loss widens to INR 526 Crore in FY22

Trying to be prudent in this macroeconomic environment: Flipkart CEO